![Long-term survival results of minimally invasive surgery in patients with uterine serous carcinoma - Gynecologic Oncology Long-term survival results of minimally invasive surgery in patients with uterine serous carcinoma - Gynecologic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/e7771609-811b-42b7-8abf-45232452b6b2/fx44.jpg)
Long-term survival results of minimally invasive surgery in patients with uterine serous carcinoma - Gynecologic Oncology
![Journal of Clinical Oncology on Twitter: "A new benchmark: the GEM20110714 study reports long-term overall survival improvement with gemcitabine/cisplatin compared to fluorouracil/cisplatin in recurrent/metastatic nasopharyngeal carcinoma https://t.co ... Journal of Clinical Oncology on Twitter: "A new benchmark: the GEM20110714 study reports long-term overall survival improvement with gemcitabine/cisplatin compared to fluorouracil/cisplatin in recurrent/metastatic nasopharyngeal carcinoma https://t.co ...](https://pbs.twimg.com/media/E9LKYRRXEAEq0Qq.jpg)
Journal of Clinical Oncology on Twitter: "A new benchmark: the GEM20110714 study reports long-term overall survival improvement with gemcitabine/cisplatin compared to fluorouracil/cisplatin in recurrent/metastatic nasopharyngeal carcinoma https://t.co ...
![a Overall survival for patients with long-term oncological outcome data... | Download Scientific Diagram a Overall survival for patients with long-term oncological outcome data... | Download Scientific Diagram](https://www.researchgate.net/publication/341770517/figure/fig2/AS:960105075974149@1605918296821/a-Overall-survival-for-patients-with-long-term-oncological-outcome-data-5-years.png)
a Overall survival for patients with long-term oncological outcome data... | Download Scientific Diagram
![Long-term survival of patients with stage II and III gastric cancer who underwent gastrectomy with inadequate nodal assessment Long-term survival of patients with stage II and III gastric cancer who underwent gastrectomy with inadequate nodal assessment](https://f6publishing.blob.core.windows.net/227ae865-2d6c-40e1-9cb2-2abecf2b4b26/WJGS-13-1463-g001.png)
Long-term survival of patients with stage II and III gastric cancer who underwent gastrectomy with inadequate nodal assessment
![JCI - Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme JCI - Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme](https://dm5migu4zj3pb.cloudfront.net/manuscripts/138000/138649/medium/JCI138649.f7.jpg)
JCI - Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme
![P119 Impact of Treatment Modality on Long-Term Survival of Small-Cell Lung Cancer with IA Stage: a Population-based Study - Journal of Thoracic Oncology P119 Impact of Treatment Modality on Long-Term Survival of Small-Cell Lung Cancer with IA Stage: a Population-based Study - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b47137e9-afe7-44af-a1ed-ccbd3bc93eb3/fx1_lrg.jpg)
P119 Impact of Treatment Modality on Long-Term Survival of Small-Cell Lung Cancer with IA Stage: a Population-based Study - Journal of Thoracic Oncology
![Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma | British Journal of Cancer Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-018-0061-6/MediaObjects/41416_2018_61_Fig1_HTML.jpg)
Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma | British Journal of Cancer
PLOS ONE: Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry
![Long-term outcome: (A) Overall survival: Median overall survival was 36.8 | Download Scientific Diagram Long-term outcome: (A) Overall survival: Median overall survival was 36.8 | Download Scientific Diagram](https://www.researchgate.net/profile/Florian-Primavesi/publication/343790364/figure/fig1/AS:926951384571907@1598013840997/Long-term-outcome-A-Overall-survival-Median-overall-survival-was-368.png)
Long-term outcome: (A) Overall survival: Median overall survival was 36.8 | Download Scientific Diagram
![Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER | British Journal of Cancer Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fbjc.2014.174/MediaObjects/41416_2014_Article_BFbjc2014174_Fig2_HTML.jpg)
Long-term survivor characteristics in HER2-positive metastatic breast cancer from registHER | British Journal of Cancer
![Long-term survival of patients with stage II and III gastric cancer who underwent gastrectomy with inadequate nodal assessment Long-term survival of patients with stage II and III gastric cancer who underwent gastrectomy with inadequate nodal assessment](https://f6publishing.blob.core.windows.net/227ae865-2d6c-40e1-9cb2-2abecf2b4b26/WJGS-13-1463-g005.png)
Long-term survival of patients with stage II and III gastric cancer who underwent gastrectomy with inadequate nodal assessment
PLOS ONE: Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry
![Long-term overall survival in patients with gastric cancer missed at... | Download Scientific Diagram Long-term overall survival in patients with gastric cancer missed at... | Download Scientific Diagram](https://www.researchgate.net/publication/356167780/figure/fig2/AS:1089308777820163@1636722859595/Long-term-overall-survival-in-patients-with-gastric-cancer-missed-at-upper-endoscopy-or.png)
Long-term overall survival in patients with gastric cancer missed at... | Download Scientific Diagram
![Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC - Journal of Thoracic Oncology Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC - Journal of Thoracic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/3b4b3b7f-ef3e-49b2-b1e3-89793b6a8627/gr1.jpg)
Long-Term Overall Survival From KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin With or Without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous NSCLC - Journal of Thoracic Oncology
![Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine | Journal of Hematology & Oncology | Full Text Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13045-019-0835-1/MediaObjects/13045_2019_835_Fig4_HTML.png)
Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine | Journal of Hematology & Oncology | Full Text
PLOS ONE: Comparison of Long-Term Survival of Patients with Solitary Large Hepatocellular Carcinoma of BCLC Stage A after Liver Resection or Transarterial Chemoembolization: A Propensity Score Analysis
PLOS ONE: Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis
![Atezolizumab Versus Chemotherapy in Patients with Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: A Long-term Overall Survival and Safety Update from the Phase 3 IMvigor211 Clinical Trial - European Urology Atezolizumab Versus Chemotherapy in Patients with Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: A Long-term Overall Survival and Safety Update from the Phase 3 IMvigor211 Clinical Trial - European Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/cdbf89c3-efeb-47c6-be6f-237ffedd1305/gr1.jpg)
Atezolizumab Versus Chemotherapy in Patients with Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: A Long-term Overall Survival and Safety Update from the Phase 3 IMvigor211 Clinical Trial - European Urology
![Survival and Prognostic Factors in Children with Brain Tumors: Long-term Follow-up Single Center Study in Poland | Anticancer Research Survival and Prognostic Factors in Children with Brain Tumors: Long-term Follow-up Single Center Study in Poland | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/34/1/323/F1.large.jpg)